The difference between HbA1c and blood sugar is a common source of confusion for people managing or at risk of diabetes. Both tests measure aspects of glucose in the body, yet they serve distinct clinical purposes and capture very different timeframes of information. Blood sugar tests provide an immediate snapshot of your glucose level at a single moment, while HbA1c reflects your average glucose control over the preceding two to three months. Understanding how each test works, what the results mean, and when each is used within NHS diabetes care can help you make better sense of your health and have more informed conversations with your GP or diabetes team.

What Is Blood Sugar and How Is It Measured?

Blood sugar (blood glucose) is the concentration of glucose in your bloodstream at any given moment, measured in mmol/L in the UK using fasting, random, OGTT, finger-prick, or continuous glucose monitoring methods.

Blood sugar, or blood glucose, refers to the concentration of glucose circulating in your bloodstream at any given moment. Glucose is the body's primary source of energy, derived from the carbohydrates you eat and drink. In people without diabetes, the body regulates blood glucose tightly through the actions of insulin — a hormone produced by the pancreas — and glucagon. When this regulatory system is disrupted, blood glucose levels can rise to harmful levels, as seen in type 1 and type 2 diabetes.

Blood glucose is measured in millimoles per litre (mmol/L) in the UK. There are several ways to measure it:

• Fasting plasma glucose (FPG): A blood test taken after at least eight hours without food or drink (other than water). It reflects your baseline glucose level.

• Random plasma glucose: A test taken at any time of day, regardless of when you last ate. It is often used when symptoms of diabetes are present.

• Oral glucose tolerance test (OGTT): A two-hour test in which blood glucose is measured before and two hours after drinking a standard glucose solution. It is used to diagnose type 2 diabetes, gestational diabetes, and non-diabetic hyperglycaemia.

• Capillary blood glucose (finger-prick testing): A self-monitoring method used primarily by people with diabetes who are on insulin or at risk of hypoglycaemia. For most adults with type 2 diabetes who are not on insulin, routine self-monitoring of blood glucose is not generally recommended by NICE (NG28) unless there is a specific clinical reason, such as assessing the impact of lifestyle changes or illness.

• Continuous glucose monitoring (CGM): A wearable sensor that measures glucose in the interstitial fluid every few minutes, providing real-time data and trend information. It is important to note that CGM measures interstitial glucose, which may lag behind blood glucose by approximately 5–10 minutes — particularly during periods of rapid change, such as after eating or during exercise.

Blood glucose readings are highly dynamic — they fluctuate throughout the day in response to meals, exercise, stress, illness, and medication. This is an important distinction when comparing them to the HbA1c test, which captures a much broader picture of glucose control over time.

What Is HbA1c and What Does It Tell You?

HbA1c measures the proportion of haemoglobin with glucose attached, reflecting a weighted average of blood glucose over the preceding 8–12 weeks; it is reported in mmol/mol by NHS laboratories.

HbA1c — formally known as glycated haemoglobin — is a blood test that measures the proportion of haemoglobin molecules in your red blood cells that have glucose attached to them. Red blood cells have a lifespan of approximately 120 days (around 17 weeks). Because newer red blood cells contribute more to the HbA1c result than older ones, the test is weighted towards the preceding 8–12 weeks, and is broadly described as reflecting your average blood glucose level over the preceding two to three months, rather than a single point-in-time measurement.

The process by which glucose attaches to haemoglobin is called glycation, and it occurs continuously and irreversibly throughout the life of a red blood cell. The higher your blood glucose levels over time, the more glycated haemoglobin accumulates. This makes HbA1c a reliable indicator of longer-term glucose exposure and overall diabetes management.

In the UK, HbA1c is reported in millimoles per mole (mmol/mol), following the IFCC (International Federation of Clinical Chemistry) standardisation adopted by the NHS. Older percentage-based values (DCCT units) may still be referenced in some patient literature, but mmol/mol is now the standard format used by NHS laboratories and NICE guidelines.

HbA1c is particularly valuable because it is not greatly affected by the short-term fluctuations caused by a single meal or a stressful day. However, it is important to understand that more recent weeks of glucose control have a greater influence on the result than earlier weeks in the period — so a significant change in glucose management in the weeks before the test will be partially reflected.

HbA1c also has important limitations. It should not be used for diagnosis in the following circumstances:

• Pregnancy or within two months of giving birth

• Children and young people

• Suspected type 1 diabetes or acute hyperglycaemic symptoms

• People with haemoglobin variants (such as sickle cell trait or thalassaemia)

• Haemolytic anaemia, iron deficiency anaemia, or recent blood transfusion — all of which affect red blood cell turnover

In these situations, plasma glucose measurements are used instead, and alternative markers such as fructosamine may occasionally be considered. These exclusions are set out in NICE guidance (NG28 and NG17).

Key Differences Between HbA1c and Blood Sugar Tests

Blood glucose tests capture an immediate snapshot in mmol/L, while HbA1c provides a weighted two-to-three-month average in mmol/mol; they serve complementary rather than interchangeable clinical roles.

Understanding the difference between HbA1c and blood sugar tests is essential for interpreting diabetes-related results accurately. Although both measure aspects of glucose in the body, they serve fundamentally different clinical purposes.

Timeframe measured:

• Blood glucose tests capture a snapshot — your glucose level at a specific moment.

• HbA1c reflects a weighted average over approximately two to three months, with more recent weeks contributing more to the result.

What they detect:

• Blood glucose tests are sensitive to immediate factors such as recent food intake, physical activity, stress, or illness.

• HbA1c is not greatly affected by these short-term variables, though sustained changes in glucose control over recent weeks will begin to be reflected in the result.

Units of measurement:

• Blood glucose is measured in mmol/L.

• HbA1c is measured in mmol/mol (or occasionally as a percentage in older literature).

Clinical use:

• Blood glucose monitoring is used for day-to-day diabetes management, hypoglycaemia detection, and medication adjustment.

• HbA1c is used for diagnosis (in appropriate circumstances), long-term monitoring, and assessing the risk of diabetes-related complications.

Frequency:

• Blood glucose can be checked multiple times daily when clinically indicated.

• HbA1c is typically measured every three to six months in people with established diabetes until results are stable, then every six months thereafter (NICE NG28, NG17). People identified with non-diabetic hyperglycaemia may be re-tested periodically according to local pathways, often every six to twelve months.

Neither test is superior to the other — they are complementary tools. A person may have a well-controlled HbA1c but still experience significant glucose variability (frequent highs and lows), which blood glucose monitoring or CGM would reveal. Conversely, a single elevated blood glucose reading does not necessarily indicate poor overall control. Using both tests together gives clinicians and patients a more complete picture of metabolic health.

When Each Test Is Used in NHS Diabetes Care

HbA1c of 48 mmol/mol or above diagnoses type 2 diabetes in asymptomatic adults; blood glucose thresholds (fasting ≥7.0 mmol/L or random ≥11.1 mmol/L with symptoms) are used when HbA1c is unsuitable.

NICE guidelines and NHS clinical pathways specify clear roles for both blood glucose and HbA1c testing across different stages of diabetes care.

HbA1c in diagnosis: According to NICE guidance (NG28), an HbA1c of 48 mmol/mol (6.5%) or above on two separate occasions is diagnostic of type 2 diabetes in asymptomatic individuals. A single result of 48 mmol/mol or above is sufficient if symptoms of diabetes are also present. An HbA1c of 42–47 mmol/mol (6.0–6.4%) indicates non-diabetic hyperglycaemia (sometimes called prediabetes), which carries a significantly elevated risk of progressing to type 2 diabetes.

HbA1c must not be used for diagnosis in the following groups: people who are pregnant or within two months of giving birth; children and young people; those with suspected type 1 diabetes or acute hyperglycaemic symptoms; and those with conditions affecting red blood cell lifespan or haemoglobin variants. In these cases, plasma glucose measurements are used. If type 1 diabetes is suspected, NICE (NG17) recommends same-day specialist assessment.

Blood glucose in diagnosis: A fasting plasma glucose of 7.0 mmol/L or above, or a random plasma glucose of 11.1 mmol/L or above in the presence of symptoms (such as polyuria, polydipsia, or unexplained weight loss), is diagnostic of diabetes. A two-hour glucose of 11.1 mmol/L or above during an oral glucose tolerance test (OGTT) is also diagnostic.

Ongoing monitoring: For people already living with diabetes:

• HbA1c is checked every three to six months until results are stable, then every six months, to assess long-term control and guide treatment decisions (NICE NG28, NG17).

• Self-monitored blood glucose (SMBG) or CGM is used by people on insulin or those at risk of hypoglycaemia to make real-time adjustments to diet, activity, and medication. For most adults with type 2 diabetes not on insulin, routine SMBG is not generally recommended unless there is a specific clinical indication.

The NHS also uses HbA1c as part of the NHS Health Check programme (OHID/NHS Health Check Best Practice Guidance) to identify people at risk of developing type 2 diabetes, enabling earlier lifestyle intervention.

Understanding Your Results and Target Ranges

A normal HbA1c is below 42 mmol/mol; type 2 diabetes targets are typically 48–53 mmol/mol depending on treatment, while blood glucose targets before meals are generally 4–7 mmol/L for both type 1 and type 2 diabetes.

Interpreting your results correctly — and understanding what they mean for your health — is an important part of managing or preventing diabetes.

HbA1c target ranges (NICE-aligned):

• Below 42 mmol/mol: Normal range — not indicative of diabetes.

• 42–47 mmol/mol: Non-diabetic hyperglycaemia (prediabetes) — lifestyle changes are recommended.

• 48 mmol/mol and above: Diagnostic of type 2 diabetes (in appropriate clinical context).

• For people with type 2 diabetes, NICE (NG28) recommends an individualised target — commonly 48 mmol/mol (6.5%) for those managed by lifestyle or metformin alone, or 53 mmol/mol (7.0%) for those on medications that carry a hypoglycaemia risk (such as insulin or sulfonylureas).

• For people with type 1 diabetes, NICE (NG17) recommends a target of 48 mmol/mol (6.5%) if achievable without problematic hypoglycaemia.

Blood glucose target ranges:

Targets differ depending on the type of diabetes and individual circumstances. The following are commonly used UK patient-facing targets:

Adults with type 1 diabetes (NICE NG17):

• On waking: 5–7 mmol/L

• Before meals: 4–7 mmol/L

• At least 90 minutes after meals: 5–9 mmol/L

Adults with type 2 diabetes (NHS/Diabetes UK):

• Before meals: 4–7 mmol/L

• Two hours after meals: below 8.5 mmol/L

Hypoglycaemia is defined as blood glucose below 4.0 mmol/L and requires prompt treatment.

It is important to remember that targets are individualised. Older adults, those with frequent hypoglycaemia, or those with significant comorbidities may have less stringent targets agreed with their diabetes team. Equally, tighter control may be appropriate for younger individuals or those planning a pregnancy. Always discuss your personal targets with your GP or diabetes specialist rather than comparing your results directly with others.

When to Speak to Your GP or Diabetes Team

Contact your GP if your HbA1c reaches 48 mmol/mol or above, or if blood glucose consistently exceeds your agreed target; seek same-day urgent help if blood glucose is above 13 mmol/L with ketones present.

Knowing when to seek medical advice is a vital aspect of safe diabetes management. Both blood glucose readings and HbA1c results can signal situations that require prompt clinical review.

Contact your GP or diabetes team if:

• Your HbA1c result comes back at 48 mmol/mol or above for the first time — this warrants further assessment and may indicate a new diagnosis of type 2 diabetes.

• Your HbA1c has risen significantly since your last test, suggesting that your current management plan may need to be reviewed.

• You are experiencing frequent hypoglycaemic episodes (blood glucose below 4.0 mmol/L), particularly if they are severe, nocturnal, or occurring without warning symptoms.

• Your blood glucose readings are consistently above your agreed target range despite following your treatment plan.

• You have symptoms that may suggest hyperglycaemia, such as increased thirst, frequent urination, blurred vision, fatigue, or slow wound healing.

Seek urgent same-day medical attention if:

• Your blood glucose is above 13 mmol/L and you feel unwell — check your blood or urine ketones. If blood ketones are 1.5 mmol/L or above, or urine ketones are moderate or large, seek same-day urgent help from your GP, diabetes team, or NHS 111. Do not wait.

• Your blood glucose is above 15 mmol/L, particularly if you have type 1 diabetes — this may indicate diabetic ketoacidosis (DKA). Symptoms of DKA include abdominal pain, vomiting, rapid or deep breathing, and signs of dehydration. This is a medical emergency.

• You experience a severe hypoglycaemic episode that you cannot treat yourself, or that causes loss of consciousness — call 999 immediately.

If you are unsure whether to go to your GP, call NHS 111 or contact your diabetes team. If you are severely unwell, call 999 or go to your nearest A&E.

If you are unsure how to interpret your results, your GP practice, diabetes specialist nurse, or structured education programme (such as DESMOND for type 2 diabetes or DAFNE for type 1) can provide personalised guidance. The NHS also offers support through the NHS Diabetes Prevention Programme for those identified with non-diabetic hyperglycaemia.

If you suspect that a medicine — such as insulin or a sulfonylurea — has caused a side effect such as hypoglycaemia, you or your healthcare professional can report this to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk. Early intervention and regular monitoring remain the most effective strategies for reducing the long-term complications of diabetes.

Experiencing these side effects? Our pharmacists can help you navigate them →

Frequently Asked Questions